TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Eli Lilly and Company (LLY)

Healthcare Drug Manufacturers - General
1,148.80 $
-0.5% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Eli Lilly and Company (LLY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.7% of the shares are freely tradable; institutional investors hold 85.4%.

Ownership Structure

Institutional ownership
85.4%
Insiders
0.2%
Float
99.7%
Short % of float
1.2%
Shares Outstanding
892Mio.

Largest Shareholders

Institutions

Institutions LLY
Name Stake (%) Shares Change (%) Date
Lilly Endowment Inc 10.13 90,376,978 -1.7 06/30/2026
BlackRock Inc 7.44 66,380,842 -0.6 03/31/2026
Vanguard Capital Management, LLC 5.98 53,361,774 +0.0 03/31/2026
PNC Financial Services Group Inc 5.76 51,328,908 +0.0 03/31/2026
State Street Corp 3.99 35,610,002 +0.7 03/31/2026
FMR Inc 2.95 26,341,031 +2.4 03/31/2026
Capital Research Global Investors 2.76 24,632,647 +0.3 03/31/2026
Vanguard Portfolio Management, LLC 2.35 20,977,027 +0.0 03/31/2026

Funds

Funds LLY
Name Stake (%) Shares Change (%) Date
Vanguard Morn Total Stk Mkt Idx Investor 3.02 26,912,148 -0.4 06/30/2026
Vanguard 500 Index Investor 2.30 20,548,671 -0.9 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
20. Jul 2026 Alvarez Ralph Director Other 11 1,146.90 12,616
20. Jul 2026 Sulzberger Gabrielle Director Other 4 1,146.90 4,588
20. Jul 2026 Luciano Juan R Director Other 14 1,146.90 16,057
20. Jul 2026 Fyrwald J Erik Director Other 9 1,146.90 10,322

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?